Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis

被引:96
|
作者
Jin, J-K [1 ,2 ]
Tien, P-C [1 ]
Cheng, C-J [3 ]
Song, J. H. [1 ]
Huang, C. [4 ]
Lin, S-H [1 ,2 ,5 ]
Gallick, G. E. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Genitourinary Med Oncol, Unit 18 4, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Metastasis, Houston, TX USA
[3] Taipei Med Univ, Dept Pathol, Coll Med, Taipei, Taiwan
[4] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA
[5] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Translat Mol Pathol, Unit 89, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
INTEGRIN EXPRESSION; BINDING; PROGRESSION; ADHESION; CARCINOMA; SUBUNIT; DOMAIN; TAILS; SITES; CELLS;
D O I
10.1038/onc.2014.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Talins are adaptor proteins that regulate focal adhesion signaling by conjugating integrins to the cytoskeleton. Talins directly bind integrins and are essential for integrin activation. We previously showed that beta 1 integrins are activated in metastatic prostate cancer (PCa) cells, increasing PCa metastasis to lymph nodes and bone. However, how beta 1 integrins are activated in PCa cells is unknown. In this study, we identified a novel mechanism of beta 1 integrin activation. Using knockdown experiments, we first demonstrated that talin1, but not talin2, is important in beta 1 integrin activation. We next showed that talin1 S425 phosphorylation, but not total talin1 expression, correlates with metastatic potential of PCa cells. Expressing a non-phosphorylatable mutant, talin1(S425A), in talin1-silenced PC3-MM2 and C4-2B4 PCa cells, decreased activation of beta 1 integrins, integrin-mediated adhesion, motility and increased the sensitivity of the cells to anoikis. In contrast, reexpression of the phosphorylation-mimicking mutant talin1(S425D) led to increased beta 1 integrin activation and generated biologic effects opposite to talin1(S425A) expression. In the highly metastatic PC3-MM2 cells, expression of a non-phosphorylatable mutant, talin1(S425A), in talin1-silenced PC3-MM2 cells, abolished their ability to colonize in the bone following intracardiac injection, while reexpression of phosphorylation-mimicking mutant talin1(S425D) restored their ability to metastasize to bone. Immunohistochemical staining demonstrated that talin S425 phosphorylation is significantly increased in human bone metastases when compared with normal tissues, primary tumors or lymph node metastases. We further showed that p35 expression, an activator of Cdk5, and Cdk5 activity were increased in metastatic tumor cells, and that Cdk5 kinase activity is responsible for talin1 phosphorylation and subsequent beta 1 integrin activation. Together, our study reveals Cdk5-mediated phosphorylation of talin1 leading to beta 1 integrin activation is a novel mechanism that increases metastatic potential of PCa cells.
引用
收藏
页码:1811 / 1821
页数:11
相关论文
共 50 条
  • [31] SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer
    Tang, Chen
    Lai, Yiming
    Li, Lingfeng
    Situ, Min-yi
    Li, Shurui
    Cheng, Bisheng
    Chen, Yongming
    Lei, Zhen
    Ren, Yanting
    Zhou, Jie
    Wu, Yongxin
    Zhong, Haitao
    Li, Kaiwen
    Zeng, Lexiang
    Guo, Zhenghui
    Peng, Shengmeng
    Huang, Hai
    [J]. ISCIENCE, 2024, 27 (08)
  • [32] REX-1 Represses RASSF1a and Activates the MEK/ERK Pathway to Promote Tumorigenesis in Prostate Cancer
    Liu, Weijing
    Xie, An
    Tu, Chunhua
    Liu, Weipeng
    [J]. MOLECULAR CANCER RESEARCH, 2021, 19 (10) : 1666 - 1675
  • [33] Treatment of Bone Metastasis in Prostate Cancer: Efficacy of a Novel Polybisphosphonate
    Daubine, Florence
    Le Bot, Ronan
    Marquez, Marcela
    Nilsson, Sten
    Schroder, Torbjorn
    Holmberg, Anders R.
    [J]. ANTICANCER RESEARCH, 2011, 31 (12) : 4141 - 4145
  • [34] NOVEL RESOURCES FOR BONE METASTASIS DIAGNOSTICS IN PROSTATE CANCER WITH THE "REZOSCAN"
    Apolikhin, O. I.
    Koryakin, A. V.
    Sivkov, A. V.
    Oshepkov, B. N.
    Rabinovitch, E. Z.
    Keshishev, N. G.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 82 - 82
  • [35] Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer
    Yu, Mengsi
    Yang, Changcheng
    Wang, Song
    Zeng, Yujie
    Chen, Zhaoyun
    Feng, Ning
    Ning, Conghua
    Wang, Lijuan
    Xue, Li
    Zhang, Zhaoxia
    [J]. CLINICA CHIMICA ACTA, 2020, 510 : 437 - 441
  • [36] MTA1 drives malignant progression and bone metastasis in prostate cancer
    Kumar, Avinash
    Dhar, Swati
    Campanelli, Gisella
    Butt, Nasir A.
    Schallheim, Jason M.
    Gomez, Christian R.
    Levenson, Anait S.
    [J]. MOLECULAR ONCOLOGY, 2018, 12 (09): : 1596 - 1607
  • [37] Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer
    Juan Liu
    Cen Zhang
    Tianliang Zhang
    Chun-Yuan Chang
    Jianming Wang
    Ludvinna Bazile
    Lanjing Zhang
    Bruce G. Haffty
    Wenwei Hu
    Zhaohui Feng
    [J]. Nature Metabolism, 2022, 4 : 1830 - 1846
  • [38] Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer
    Liu, Juan
    Zhang, Cen
    Zhang, Tianliang
    Chang, Chun-Yuan
    Wang, Jianming
    Bazile, Ludvinna
    Zhang, Lanjing
    Haffty, Bruce G. G.
    Hu, Wenwei
    Feng, Zhaohui
    [J]. NATURE METABOLISM, 2022, 4 (12) : 1830 - +
  • [39] Mechanism of SERPINH1 in promoting bone metastasis of prostate cancer by inhibiting P62 ubiquitination degradation
    Huang, H.
    Chen, T.
    Zhen, L.
    Yiming, L.
    Shengmeng, P.
    Yongming, C.
    Lingfeng, L.
    Jie, Z.
    Zhenghui, G.
    [J]. EUROPEAN UROLOGY, 2023, 83
  • [40] Sevoflurane activates the IL-6/HO-1 pathway to promote macrophage M2 polarization and prostate cancer lung metastasis
    Yu, Fang
    Bai, Tao
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113